世界のメシル酸イマチニブ錠市場予測2023-2029：100 mg、400 mg

【英語タイトル】Imatinib Mesylate Tablets Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8801
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：68
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のメシル酸イマチニブ錠市場規模と予測を収録しています。・世界のメシル酸イマチニブ錠市場：売上、2018年-2023年、2024年-2029年
・世界のメシル酸イマチニブ錠市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のメシル酸イマチニブ錠市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「100 mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

メシル酸イマチニブ錠のグローバル主要企業は、Teva Pharmaceuticals、 Hikma Pharmaceuticals、 Apotex Inc、 Sun Pharmaceutical Industries、 Lupin Limited、 Natco Pharma、 Getwell Oncologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、メシル酸イマチニブ錠のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のメシル酸イマチニブ錠市場：タイプ別、2018年-2023年、2024年-2029年
世界のメシル酸イマチニブ錠市場：タイプ別市場シェア、2022年
・100 mg、400 mg

世界のメシル酸イマチニブ錠市場：用途別、2018年-2023年、2024年-2029年
世界のメシル酸イマチニブ錠市場：用途別市場シェア、2022年
・病院、クリニック

世界のメシル酸イマチニブ錠市場：地域・国別、2018年-2023年、2024年-2029年
世界のメシル酸イマチニブ錠市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるメシル酸イマチニブ錠のグローバル売上、2018年-2023年
・主要企業におけるメシル酸イマチニブ錠のグローバル売上シェア、2022年
・主要企業におけるメシル酸イマチニブ錠のグローバル販売量、2018年-2023年
・主要企業におけるメシル酸イマチニブ錠のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Teva Pharmaceuticals、 Hikma Pharmaceuticals、 Apotex Inc、 Sun Pharmaceutical Industries、 Lupin Limited、 Natco Pharma、 Getwell Oncology

*************************************************************

・調査・分析レポートの概要
メシル酸イマチニブ錠市場の定義
市場セグメント
世界のメシル酸イマチニブ錠市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のメシル酸イマチニブ錠市場規模
世界のメシル酸イマチニブ錠市場規模：2022年 VS 2029年
世界のメシル酸イマチニブ錠市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのメシル酸イマチニブ錠の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のメシル酸イマチニブ錠製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：100 mg、400 mg
メシル酸イマチニブ錠のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック
メシル酸イマチニブ錠の用途別グローバル売上・予測

・地域別市場分析
地域別メシル酸イマチニブ錠市場規模 2022年と2029年
地域別メシル酸イマチニブ錠売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Teva Pharmaceuticals、 Hikma Pharmaceuticals、 Apotex Inc、 Sun Pharmaceutical Industries、 Lupin Limited、 Natco Pharma、 Getwell Oncology
...

This report aims to provide a comprehensive presentation of the global market for Imatinib Mesylate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Mesylate Tablets. This report contains market size and forecasts of Imatinib Mesylate Tablets in global, including the following market information:
Global Imatinib Mesylate Tablets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Imatinib Mesylate Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
100 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Imatinib Mesylate Tablets include Teva Pharmaceuticals, Hikma Pharmaceuticals, Apotex Inc, Sun Pharmaceutical Industries, Lupin Limited, Natco Pharma and Getwell Oncology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Imatinib Mesylate Tablets companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Imatinib Mesylate Tablets Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Imatinib Mesylate Tablets Market Segment Percentages, by Type, 2022 (%)
100 mg
400 mg
Global Imatinib Mesylate Tablets Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Imatinib Mesylate Tablets Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Global Imatinib Mesylate Tablets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Imatinib Mesylate Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Imatinib Mesylate Tablets revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Imatinib Mesylate Tablets revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceuticals
Hikma Pharmaceuticals
Apotex Inc
Sun Pharmaceutical Industries
Lupin Limited
Natco Pharma
Getwell Oncology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Imatinib Mesylate Tablets, market overview.
Chapter 2: Global Imatinib Mesylate Tablets market size in revenue.
Chapter 3: Detailed analysis of Imatinib Mesylate Tablets company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Imatinib Mesylate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Imatinib Mesylate Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Imatinib Mesylate Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Imatinib Mesylate Tablets Overall Market Size
2.1 Global Imatinib Mesylate Tablets Market Size: 2022 VS 2029
2.2 Global Imatinib Mesylate Tablets Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Imatinib Mesylate Tablets Players in Global Market
3.2 Top Global Imatinib Mesylate Tablets Companies Ranked by Revenue
3.3 Global Imatinib Mesylate Tablets Revenue by Companies
3.4 Top 3 and Top 5 Imatinib Mesylate Tablets Companies in Global Market, by Revenue in 2022
3.5 Global Companies Imatinib Mesylate Tablets Product Type
3.6 Tier 1, Tier 2 and Tier 3 Imatinib Mesylate Tablets Players in Global Market
3.6.1 List of Global Tier 1 Imatinib Mesylate Tablets Companies
3.6.2 List of Global Tier 2 and Tier 3 Imatinib Mesylate Tablets Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Imatinib Mesylate Tablets Market Size Markets, 2022 & 2029
4.1.2 100 mg
4.1.3 400 mg
4.2 By Type – Global Imatinib Mesylate Tablets Revenue & Forecasts
4.2.1 By Type – Global Imatinib Mesylate Tablets Revenue, 2018-2023
4.2.2 By Type – Global Imatinib Mesylate Tablets Revenue, 2024-2029
4.2.3 By Type – Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Imatinib Mesylate Tablets Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.2 By Application – Global Imatinib Mesylate Tablets Revenue & Forecasts
5.2.1 By Application – Global Imatinib Mesylate Tablets Revenue, 2018-2023
5.2.2 By Application – Global Imatinib Mesylate Tablets Revenue, 2024-2029
5.2.3 By Application – Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Imatinib Mesylate Tablets Market Size, 2022 & 2029
6.2 By Region – Global Imatinib Mesylate Tablets Revenue & Forecasts
6.2.1 By Region – Global Imatinib Mesylate Tablets Revenue, 2018-2023
6.2.2 By Region – Global Imatinib Mesylate Tablets Revenue, 2024-2029
6.2.3 By Region – Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Imatinib Mesylate Tablets Revenue, 2018-2029
6.3.2 US Imatinib Mesylate Tablets Market Size, 2018-2029
6.3.3 Canada Imatinib Mesylate Tablets Market Size, 2018-2029
6.3.4 Mexico Imatinib Mesylate Tablets Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Imatinib Mesylate Tablets Revenue, 2018-2029
6.4.2 Germany Imatinib Mesylate Tablets Market Size, 2018-2029
6.4.3 France Imatinib Mesylate Tablets Market Size, 2018-2029
6.4.4 U.K. Imatinib Mesylate Tablets Market Size, 2018-2029
6.4.5 Italy Imatinib Mesylate Tablets Market Size, 2018-2029
6.4.6 Russia Imatinib Mesylate Tablets Market Size, 2018-2029
6.4.7 Nordic Countries Imatinib Mesylate Tablets Market Size, 2018-2029
6.4.8 Benelux Imatinib Mesylate Tablets Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Imatinib Mesylate Tablets Revenue, 2018-2029
6.5.2 China Imatinib Mesylate Tablets Market Size, 2018-2029
6.5.3 Japan Imatinib Mesylate Tablets Market Size, 2018-2029
6.5.4 South Korea Imatinib Mesylate Tablets Market Size, 2018-2029
6.5.5 Southeast Asia Imatinib Mesylate Tablets Market Size, 2018-2029
6.5.6 India Imatinib Mesylate Tablets Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Imatinib Mesylate Tablets Revenue, 2018-2029
6.6.2 Brazil Imatinib Mesylate Tablets Market Size, 2018-2029
6.6.3 Argentina Imatinib Mesylate Tablets Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Imatinib Mesylate Tablets Revenue, 2018-2029
6.7.2 Turkey Imatinib Mesylate Tablets Market Size, 2018-2029
6.7.3 Israel Imatinib Mesylate Tablets Market Size, 2018-2029
6.7.4 Saudi Arabia Imatinib Mesylate Tablets Market Size, 2018-2029
6.7.5 UAE Imatinib Mesylate Tablets Market Size, 2018-2029
7 Imatinib Mesylate Tablets Companies Profiles
7.1 Teva Pharmaceuticals
7.1.1 Teva Pharmaceuticals Company Summary
7.1.2 Teva Pharmaceuticals Business Overview
7.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Major Product Offerings
7.1.4 Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.1.5 Teva Pharmaceuticals Key News & Latest Developments
7.2 Hikma Pharmaceuticals
7.2.1 Hikma Pharmaceuticals Company Summary
7.2.2 Hikma Pharmaceuticals Business Overview
7.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Major Product Offerings
7.2.4 Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.2.5 Hikma Pharmaceuticals Key News & Latest Developments
7.3 Apotex Inc
7.3.1 Apotex Inc Company Summary
7.3.2 Apotex Inc Business Overview
7.3.3 Apotex Inc Imatinib Mesylate Tablets Major Product Offerings
7.3.4 Apotex Inc Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.3.5 Apotex Inc Key News & Latest Developments
7.4 Sun Pharmaceutical Industries
7.4.1 Sun Pharmaceutical Industries Company Summary
7.4.2 Sun Pharmaceutical Industries Business Overview
7.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Major Product Offerings
7.4.4 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.4.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.5 Lupin Limited
7.5.1 Lupin Limited Company Summary
7.5.2 Lupin Limited Business Overview
7.5.3 Lupin Limited Imatinib Mesylate Tablets Major Product Offerings
7.5.4 Lupin Limited Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.5.5 Lupin Limited Key News & Latest Developments
7.6 Natco Pharma
7.6.1 Natco Pharma Company Summary
7.6.2 Natco Pharma Business Overview
7.6.3 Natco Pharma Imatinib Mesylate Tablets Major Product Offerings
7.6.4 Natco Pharma Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.6.5 Natco Pharma Key News & Latest Developments
7.7 Getwell Oncology
7.7.1 Getwell Oncology Company Summary
7.7.2 Getwell Oncology Business Overview
7.7.3 Getwell Oncology Imatinib Mesylate Tablets Major Product Offerings
7.7.4 Getwell Oncology Imatinib Mesylate Tablets Revenue in Global Market (2018-2023)
7.7.5 Getwell Oncology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Imatinib Mesylate Tablets Market Opportunities & Trends in Global Market
Table 2. Imatinib Mesylate Tablets Market Drivers in Global Market
Table 3. Imatinib Mesylate Tablets Market Restraints in Global Market
Table 4. Key Players of Imatinib Mesylate Tablets in Global Market
Table 5. Top Imatinib Mesylate Tablets Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Imatinib Mesylate Tablets Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Imatinib Mesylate Tablets Revenue Share by Companies, 2018-2023
Table 8. Global Companies Imatinib Mesylate Tablets Product Type
Table 9. List of Global Tier 1 Imatinib Mesylate Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Imatinib Mesylate Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Imatinib Mesylate Tablets Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Imatinib Mesylate Tablets Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Imatinib Mesylate Tablets Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Imatinib Mesylate Tablets Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Imatinib Mesylate Tablets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue, (US$, Mn), 2024-2029
Table 30. Teva Pharmaceuticals Company Summary
Table 31. Teva Pharmaceuticals Imatinib Mesylate Tablets Product Offerings
Table 32. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 33. Teva Pharmaceuticals Key News & Latest Developments
Table 34. Hikma Pharmaceuticals Company Summary
Table 35. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product Offerings
Table 36. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 37. Hikma Pharmaceuticals Key News & Latest Developments
Table 38. Apotex Inc Company Summary
Table 39. Apotex Inc Imatinib Mesylate Tablets Product Offerings
Table 40. Apotex Inc Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 41. Apotex Inc Key News & Latest Developments
Table 42. Sun Pharmaceutical Industries Company Summary
Table 43. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product Offerings
Table 44. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 45. Sun Pharmaceutical Industries Key News & Latest Developments
Table 46. Lupin Limited Company Summary
Table 47. Lupin Limited Imatinib Mesylate Tablets Product Offerings
Table 48. Lupin Limited Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 49. Lupin Limited Key News & Latest Developments
Table 50. Natco Pharma Company Summary
Table 51. Natco Pharma Imatinib Mesylate Tablets Product Offerings
Table 52. Natco Pharma Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 53. Natco Pharma Key News & Latest Developments
Table 54. Getwell Oncology Company Summary
Table 55. Getwell Oncology Imatinib Mesylate Tablets Product Offerings
Table 56. Getwell Oncology Imatinib Mesylate Tablets Revenue (US$, Mn) & (2018-2023)
Table 57. Getwell Oncology Key News & Latest Developments
List of Figures
Figure 1. Imatinib Mesylate Tablets Segment by Type in 2022
Figure 2. Imatinib Mesylate Tablets Segment by Application in 2022
Figure 3. Global Imatinib Mesylate Tablets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Imatinib Mesylate Tablets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Imatinib Mesylate Tablets Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Imatinib Mesylate Tablets Revenue in 2022
Figure 8. By Type - Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 9. By Application - Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 10. By Type - Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 12. By Application - Global Imatinib Mesylate Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 14. By Region - Global Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 15. By Country - North America Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 16. US Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 20. Germany Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 21. France Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 28. China Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 32. India Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 34. Brazil Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Imatinib Mesylate Tablets Revenue Market Share, 2018-2029
Figure 37. Turkey Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Imatinib Mesylate Tablets Revenue, (US$, Mn), 2018-2029
Figure 41. Teva Pharmaceuticals Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Hikma Pharmaceuticals Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Apotex Inc Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lupin Limited Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Natco Pharma Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Getwell Oncology Imatinib Mesylate Tablets Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

★調査レポート[世界のメシル酸イマチニブ錠市場予測2023-2029：100 mg、400 mg] (コード：MMG23LY8801)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のメシル酸イマチニブ錠市場予測2023-2029：100 mg、400 mg]についてメールでお問い合わせ

MarketReport.jp

世界のメシル酸イマチニブ錠市場予測2023-2029：100 mg、400 mg

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp